Orange County Register |

UC Irvine experiment allows a paraplegic to walk via brain control for the first time

Researchers use new technology to get patients with spinal cord damage on their feet.

Santa Cruz Sentinel |

Organic diet cuts pesticide exposure in children

A new UC Berkeley study demonstrates how nutritional changes can lower the amount of insecticide traces in kids.

Carry the One Radio |

Me, myself & my microbiome

UCSF's Katie Pollard discusses the nearly 5 pounds of bacteria living with each of us, known as the human microbiome.

KQED |

New six-hour Zika test could be ready soon

A UC San Francisco doctor is testing a device to reduce diagnostic turnaround from three months to six hours.

Orange County Register |

Waging a mosquito war

UC Irvine researcher wants to get rid of malaria, Zika and more.

Scientific American |

'Schizophrenia gene' discovery sheds light on possible cause

A UC San Diego scientist weighs in on an important new schizophrenia study.

The Wall Street Journal |

A bright approach to brain implants

New light-based brain implants and brain reading research from UC Berkeley could lead to more targeted therapies for neural damage.

Sacramento Business Journal |

A mixtape for treating dementia

Researchers at UC Davis are studying whether a personalized list of favorite songs reduces dementia patients' need for medication.

UC Davis |

Pigeons can distinguish cancerous breast tissue from normal

Study finds the birds are uncommonly good at distinguishing cancerous breast tissue from normal .

UCLA |

Check air quality with your phone

UCLA's AirForU app lets users check for unsafe smog levels anywhere in the U.S. — especially useful for asthmatics or others with respiratory problems.

New York Times |

Eating organic lowers pesticide levels in children

New research from UC Berkeley shows that switching from conventional to organic fruits and vegetables, even for just a few days, significantly reduces pesticide levels in children’s bodies.

San Francisco Chronicle |

UCSF researcher unveils promising new drug for MS patients

Late-phase trials found that the drug greatly reduced symptoms for progressive multiple sclerosis as well as a more common form of the disease.